cgmp regulations Options
No. 21 CFR 211.113(a) needs proper published processes to be established and adopted through manufacturing to prevent objectionable microorganisms in drug products not required to be sterile. In addition, the next paragraph of USP General Chapter Antimicrobial Usefulness Testing reads: Antimicrobial preservatives really should not be utili